Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC HEPATITIS B”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02952924
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 192
Not applicableStudy completedNCT01337479
What this trial is testing

A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials

Who this might be right for
Hepatitis B
Bristol-Myers Squibb 1,097
Not applicableStudy completedNCT03329820
What this trial is testing

Quality of Life and Health Utility of Patients With CHB Infections

Who this might be right for
Chronic Hepatitis B Infection
The University of Hong Kong 589
Testing effectiveness (Phase 2)Study completedNCT04465890
What this trial is testing

A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Ascletis Pharmaceuticals Co., Ltd. 207
Not applicableUnknownNCT00155103
What this trial is testing

Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma

Who this might be right for
Hepatitis BCarcinoma, HepatocellularPolymorphism, Genetic
National Taiwan University Hospital 1,600
Not applicableStudy completedNCT05317260
What this trial is testing

Steatohepatitis in Chronic Hepatitis B

Who this might be right for
Fatty LiverChronic Hepatitis b
Mahidol University 408
Early research (Phase 1)Study completedNCT03038113
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hoffmann-La Roche 119
Not applicableUnknownNCT02412592
What this trial is testing

Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 260
Early research (Phase 1)Study completedNCT00426712
What this trial is testing

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 42
Testing effectiveness (Phase 2)Study completedNCT01706575
What this trial is testing

Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 76
Not applicableStudy completedNCT02201407
What this trial is testing

An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 50
Large-scale testing (Phase 3)Study completedNCT01300234
What this trial is testing

Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B
GlaxoSmithKline 512
Testing effectiveness (Phase 2)Study completedNCT02646163
What this trial is testing

Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients

Who this might be right for
Hepatitis B, Chronic
Replicor Inc. 8
Not applicableUnknownNCT04585165
What this trial is testing

User-friendly HIV Testing and Counseling Services

Who this might be right for
HIV InfectionsSexually Transmitted InfectionHepatitis B, Chronic+1 more
Institut de Recherche pour le Developpement 3,000
Post-approval studies (Phase 4)Looking for participantsNCT04588077
What this trial is testing

Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

Who this might be right for
Hepatitis BCirrhosis, LiverChronic Liver Disease
Mercy Medical Center 200
Not applicableStudy completedNCT02689245
What this trial is testing

Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 64
Large-scale testing (Phase 3)Study completedNCT00410072
What this trial is testing

Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb 669
Not applicableStudy completedNCT04264312
What this trial is testing

Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

Who this might be right for
Hepatitis B
Wu Jiang 76,220
Testing effectiveness (Phase 2)Study completedNCT06550128
What this trial is testing

Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

Who this might be right for
Hepatitis B, Chronic
Ausper Biopharma Co., Ltd. 86
Not applicableNot Yet RecruitingNCT07274345
What this trial is testing

Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients

Who this might be right for
Chronic Hepatitis B - Antiviral Drug Resistance - Hepatitis B Virus (HBV) Infection
Amira Mohamed Zidan 2,000
Next Page